Leadership medical team of approx 50 in nine countries across Europe and Asia Pacific. Development of medical strategy for portfolio consisting of Influenza and respiratory virus vaccines. In Australia also includes pharmaceuticals for Allergy, Neurology, Nephrology, Ophthalmology, Iron, Cardiovascular, Psychiatry, Inlicensed vaccines as well as Antivenoms. Accountable for budget management of OPEX and Headcount.Fostered high engagement of teams:2024 employee survey engagement index=85% Focus on value of medical through insightful scientific exchange, high quality medical education and evidence generation. Systematized strategic medical planning for brand plans. Co-led joint high level review of brand plans with Commercial Head. Led regional efforts to clarify evidence gaps in Europe to inform Centre for Outcome Research and Epidemiology (CORE) that led to large RWE study. Engaged with investigators around investigator-initiated research for products. Improved regional- global information flows and best practice sharing through monthly meeting that I suggested and co-chair. Demonstrated strong collegiate partnership with regional commercial head based in Europe and both of her leaders in each region. Initiated regional R&D -Medical meetings to increase communication and collaboration with colleagues from R&D. Close working with Regulatory, Communications, Market Access Policy and Government Affairs.Led responses to external evaluations of evidence Proactive member of Global Medical Affairs Leadership team with particular focus on initiatives around development of our teams. Mentoring of colleagues.

Leading medical affairs team in AsiaPacific . Influenza plus inlicensed products(vaccines, analgesia, neurology, psychiatry, allergy, antivenoms).Medical lead globally on CoV2 vaccine in collaboration with UQExternal scientific exchange with physicians and other key stakeholders including governmentsEvidence generation focus on RWDMedical EducationFractional appointment as GP in COVID vax clinic at Royal Exhibition Building run by St Vincent s Health

Country Medical Director for BMS in Australia and NZ since 2016 in fields of Immuno-Oncology, Cardiovascular, Immunology and Haematology. Leadership of a medical affairs team of 27. Priorities: translating and generating good science, collaboration with external and internal stakeholders and scientific influencing in order to optimise patient care and access to medicines.

Immunology, Virology, Neurology and Oncology. Medical team of 42, including MSLs and Medical Managers, med info, PV. Promoted from Head of Medical Virology (Mar-Oct 2014)

Head of Medical Affairs for bioCSL , providing medical affairs support for portfolio of vaccines and pharmaceuticals for Melbourne based pharmaceutical company. External engagement with key stakeholders including physicians, government and partner companies. Management of medical governance including code compliance and medical information service. Leadership of team of 12, with 3 direct reports. Parliamentary meetings on behalf of company. Support to health economics on PBAC applications. Worked with global influenza team to present and publish new data from RCT.

Global leadership of medical affairs for dolutegravir (Tivicay) accountable for -Phase 3b4 plans development and partnership with clinical operations for implementation -External engagement with key physicians and scientists-Expanded Access Program -Training of medical affairs and commercial teams -Leadership of implementation process through three regions (North America, Europe and International) and local operating companies-Partnership with internal stakeholders for launch5 direct and indirect reports located around the globe. Responsible for Global Medical Affairs Budget for asset.

Country Medical Director for ViiV Healthcare in Australia .Phase 3 research program implementation and investigator initiated studies. Liaison with external experts including leading advisory boards. Active member of brand teamsPromoted to Global Medical Lead for dolutegravir after 18 months.

Senior research fellow at Deakin University during time working in clinic.

Worked in busy primary care clinic with special interest in HIV, Hepatitis and Sexual Health. Managing Partner in practice from 1993-2001. Involved in multiple clinical research studies both as principal investigator and as site in multi-centred RCTs. Membership of Australian and Victorian Ministerial Advisory Committees on HIV, Hepatitis and Related diseases. Awarded Adjunct Associate Professor from University of Sydney for leadership of primary care of HIV.

HIV Referral Clinic, Melbourne Sexual Health Centre (one session per week

HIV/STI Clinic, Fairfield/Alfred Hospitals, Melbourne (one session per week

Short-term secondment to help launch the GP pandemic preparedness workbook and information kit that was sent to all Victorian General practices . Contributed extensively to RACGP pandemic kit that was supported by the Australian government.